Literature DB >> 27566604

The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.

Noriko Wada1, Yukinori Kurokawa2, Yasuhiro Miyazaki1, Tomoki Makino1, Tsuyoshi Takahashi1, Makoto Yamasaki1, Kiyokazu Nakajima1, Shuji Takiguchi1, Masaki Mori1, Yuichiro Doki1.   

Abstract

PURPOSE: Although carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 are the most commonly used tumor markers in gastric cancer, the differences in the characteristics of these two markers remain unclear, because most previous studies have included many patients who were positive for both markers.
METHODS: We analyzed the available data on 1050 patients with gastric cancer who underwent R0 resection. The background characteristics and recurrence-free survivals (RFS) were compared between the single-positive patients for CEA or CA 19-9 and double-negative patients.
RESULTS: Among these 1050 patients, 86 patients (8.2 %) were positive for CEA only, 77 patients (7.3 %) were positive for CA 19-9 only, and 867 patients (82.6 %) were double negative for both markers. Patients who were elderly, male and had a differentiated histology were more commonly observed in the CEA-positive group than in the double-negative group (P = 0.004, P = 0.009, and P = 0.001). The patients who were positive for either CEA or CA 19-9 had a significantly worse RFS than the patients who were negative for both (P < 0.001 and P < 0.001). The most frequent site of recurrence was the liver (9.3 %) in the CEA-positive group and the peritoneum (11.7 %) in the CA 19-9-positive group.
CONCLUSION: Age, sex, and histological type were thus found to be associated with CEA positivity. CEA is, therefore, considered to be a sensitive marker for liver recurrence, while CA 19-9 is a sensitive marker for peritoneal recurrence.

Entities:  

Keywords:  CA 19-9; CEA; Gastric cancer

Mesh:

Substances:

Year:  2016        PMID: 27566604     DOI: 10.1007/s00595-016-1408-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

1.  The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA.

Authors:  N Duraker; A N Celik
Journal:  J Surg Oncol       Date:  2001-04       Impact factor: 3.454

2.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.

Authors:  Mitsuro Kanda; Tsutomu Fujii; Hideki Takami; Masaya Suenaga; Yoshikuni Inokawa; Suguru Yamada; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Yasuhiro Kodera
Journal:  Surg Today       Date:  2013-10-09       Impact factor: 2.549

Review 4.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

5.  Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.

Authors:  M J Gaspar; I Arribas; M C Coca; M Díez-Alonso
Journal:  Tumour Biol       Date:  2001 Sep-Oct

6.  Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells.

Authors:  J Fantini; J B Rognoni; J M Culouscou; G Pommier; J Marvaldi; A Tirard
Journal:  J Cell Physiol       Date:  1989-10       Impact factor: 6.384

Review 7.  Role of tumour markers, cytogenetics.

Authors:  R Lamerz
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

8.  Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.

Authors:  Johanna Louhimo; Arto Kokkola; Henrik Alfthan; Ulf-Håkan Stenman; Caj Haglund
Journal:  Int J Cancer       Date:  2004-10-10       Impact factor: 7.396

9.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

10.  Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation.

Authors:  Y Kodera; K Isobe; M Yamauchi; T Satta; T Hasegawa; S Oikawa; K Kondoh; S Akiyama; K Itoh; I Nakashima
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more
  20 in total

1.  Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.

Authors:  Hiroaki Mieno; Keishi Yamashita; Kei Hosoda; Hiromitsu Moriya; Katsuhiko Higuchi; Mizutomo Azuma; Shouko Komori; Tsutomu Yoshida; Satoshi Tanabe; Wasaburo Koizumi; Natsuya Katada; Masahiko Watanabe
Journal:  Surg Today       Date:  2017-04-01       Impact factor: 2.549

2.  Safety and feasibility of laparoscopic gastrectomy for gastric cancer patients with a history of abdominal surgery.

Authors:  Kotaro Yamashita; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yasunori Masuike; Masaaki Motoori; Yutaka Kimura; Yukinori Kurokawa; Tomoki Makino; Makoto Yamasaki; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2017-03-20       Impact factor: 2.549

3.  The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer.

Authors:  Hiroshi Sawayama; Masaaki Iwatsuki; Daisuke Kuroda; Tasuku Toihata; Tomoyuki Uchihara; Yuki Koga; Taisuke Yagi; Yuki Kiyozumi; Tsugio Eto; Yukiharu Hiyoshi; Takatsugu Ishimoto; Yoshifumi Baba; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2018-06-20       Impact factor: 2.549

4.  Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer.

Authors:  Tsutomu Namikawa; Yasuhiro Kawanishi; Kazune Fujisawa; Eri Munekage; Jun Iwabu; Masaya Munekage; Hiromichi Maeda; Hiroyuki Kitagawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Surg Today       Date:  2017-10-17       Impact factor: 2.549

5.  The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9.

Authors:  Shun Zhang; Jing-Ze Li; Tao Du; Hai-Qiang Li; Ren-Hao Hu; Chi-Ye Ma; Xi-Mao Cui; Chun Song; Xiao-Hua Jiang
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-13

6.  Meprin α combined with CEA and CA19-9 improves prognostic prediction for surgically treated colorectal cancer patients.

Authors:  Hongfa Hou; Xinmin Gou; Juyuan Bu; Yonghui Su; Xinying Wei; Xiao Wang; Bingzong Hou
Journal:  Int J Clin Exp Pathol       Date:  2017-10-01

7.  E-Cadherin Protein as a Potential Marker for Gastric Cancer and Its Association with Helicobacter Pylori- Induced Gastritis and Gastric Ulcer.

Authors:  Mustafa Kahtan Al-Bayaty; Salma Abdul-Rudha Abass; Mohammed Faraj Al-Marjani
Journal:  Rep Biochem Mol Biol       Date:  2019-10

8.  Exosomal Protease Cargo as Prognostic Biomarker in Colorectal Cancer.

Authors:  Natalia V Yunusova; Elena A Zambalova; Marina R Patysheva; Elena S Kolegova; Sergey G Afanas'ev; Olga V Cheremisina; Alina E Grigor'eva; Svetlana N Tamkovich; Irina V Kondakova
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

9.  Carbohydrate Antigen 19-9-Positive Gastric Adenocarcinoma: Autopsy Findings and Review of the Literature.

Authors:  Tan Wang; Yoko Matsuda; Atsuko Seki; Keisuke Nonaka; Mototsune Kakizaki; Daita Kaneda; Junko Takahashi-Fujigasaki; Shigeo Murayama; Tomio Arai
Journal:  Case Rep Gastroenterol       Date:  2017-09-26

10.  Diagnostic accuracy of DNA methylation in detection of gastric cancer: a meta-analysis.

Authors:  Weiling Hu; Wenfang Zheng; Qifang Liu; Hua Chu; Shujie Chen; John J Kim; Jiaguo Wu; Jianmin Si
Journal:  Oncotarget       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.